GB201117693D0 - Combination - Google Patents
CombinationInfo
- Publication number
- GB201117693D0 GB201117693D0 GBGB1117693.0A GB201117693A GB201117693D0 GB 201117693 D0 GB201117693 D0 GB 201117693D0 GB 201117693 A GB201117693 A GB 201117693A GB 201117693 D0 GB201117693 D0 GB 201117693D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1117693.0A GB201117693D0 (en) | 2011-10-13 | 2011-10-13 | Combination |
| JP2014504392A JP6093755B2 (en) | 2011-04-14 | 2012-04-13 | Administration regimen of a combination of sapacitabine and decitabine to treat acute myeloid leukemia |
| US14/111,430 US10226478B2 (en) | 2011-04-14 | 2012-04-13 | Dosage regimen for sapacitabine and decitabine in combination for treating acute myeloid leukemia |
| HUE12717824A HUE046177T2 (en) | 2011-04-14 | 2012-04-13 | Dosage regimen for sapacitabine and decitabine in combination for treating acute myeloid leukemia |
| PL12717824T PL2696878T3 (en) | 2011-04-14 | 2012-04-13 | Dosage regimen for sapacitabine and decitabine in combination for treating acute myeloid leukemia |
| EP12717824.2A EP2696878B1 (en) | 2011-04-14 | 2012-04-13 | Dosage regimen for sapacitabine and decitabine in combination for treating acute myeloid leukemia |
| PCT/GB2012/050815 WO2012140436A1 (en) | 2011-04-14 | 2012-04-13 | Dosage regimen for sapacitabine and decitabine in combination for treating acute myeloid leukemia |
| ES12717824T ES2743691T3 (en) | 2011-04-14 | 2012-04-13 | Dosage regimen for sapacitabine and decitabine in combination to treat acute myeloid leukemia |
| EP19176614.6A EP3560501A1 (en) | 2011-04-14 | 2012-04-13 | Dosage regimen for sapacitabine and decitabine in combination for treating acute myeloid leukemia |
| US16/249,274 US20190314396A1 (en) | 2011-04-14 | 2019-01-16 | Dosage regimen for sapacitabine and decitabine in combination for treating acute myeloid leukemia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1117693.0A GB201117693D0 (en) | 2011-10-13 | 2011-10-13 | Combination |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201117693D0 true GB201117693D0 (en) | 2011-11-23 |
Family
ID=45091993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1117693.0A Ceased GB201117693D0 (en) | 2011-04-14 | 2011-10-13 | Combination |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB201117693D0 (en) |
-
2011
- 2011-10-13 GB GBGB1117693.0A patent/GB201117693D0/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201118784D0 (en) | Djml | |
| EP2754063A4 (en) | Smb2 scaleout | |
| AP2014007621A0 (en) | 2-Thiopyrimidinones | |
| ZA201304139B (en) | Combination | |
| PL2606715T3 (en) | Baler-wrapper combination | |
| GB201214881D0 (en) | Abdeckeinrichtung | |
| DK2770906T3 (en) | Applanationstonometer | |
| GB201103926D0 (en) | Lock-alarm | |
| GB201210292D0 (en) | Hydraulischer antrieb | |
| GB201121105D0 (en) | Combination | |
| GB201117693D0 (en) | Combination | |
| GB201116007D0 (en) | Combination | |
| GB201106339D0 (en) | Combination | |
| GB201105785D0 (en) | Thermo-Symbiotic-Gaming | |
| GB201110829D0 (en) | Bookworm | |
| GB201101931D0 (en) | Kerbknight | |
| GB201102066D0 (en) | Scottscraper | |
| GB201102519D0 (en) | Mirrorcane | |
| GB201102755D0 (en) | Protectaridge | |
| GB201101269D0 (en) | Hyging | |
| GB201104071D0 (en) | Eds-max | |
| GB201104240D0 (en) | Quantocosmocrypt | |
| GB201105614D0 (en) | Thermo-Symbiotic-Gaming | |
| GB201101204D0 (en) | Swiftnut | |
| GB201106767D0 (en) | McDoughnut |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |